// App-Quantinova.ai

1364 : Chronic Inhibition of Mitochondrial Translation Alters Metabolism and Stemness in AML

Researchers

Presenter

  • Shrivani Sriskanthadevan

Principal Investigators

  • Marko Skrtic

  • Mark D. Minden

  • Aaron D. Schimmer

  • Mahadeo A. Sukhai

  • Veronique Voisin

  • Yulia Jitkova

  • Marcela Gronda

  • Rose Hurren

  • Xiaoming Wang

  • Rob C. Laister

  • Gary D. Bader

Medical Centers

  • Ontario Cancer Institute, Princess Margaret Hospital, University Health Network, Toronto, ON, Canada

  • Princess Margaret Hospital, Toronto, ON, Canada

  • The Donnelly Centre, Toronto, ON, Canada

  • Department of Surgery, University of Toronto, Toronto, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Tuberculosis

Biomarkers

  • Enolase 2

  • Hypoxia-inducible factor-1

Drug/Treatment

  • Tigecycline

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved